EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation

Jennifer R Devlin, Ben Martin, Nenad Bartonicek, Keziah Ting, Zheng Fan, Izabela Todorovski, Filip Bjelosevic, Sandra Verschoor, Annette Ciccone, Joseph A Trapani, Attila Horvath, Emily Tinsley und 8 weitere

Molecular Cell · 2025-09 · 85 (17) · 3256-3274.e14

DOI: 10.1016/j.molcel.2025.08.001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2025-09. Verfasst von Jennifer R Devlin und 19 weiteren Autor:innen. Beteiligte Einrichtung: The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia; Peter MacCallum Cancer Centre, Laboratory Re…. Hauptthemen laut MEDLINE: Cyclin-Dependent Kinase 9, RNA Polymerase II, Cyclin-Dependent Kinases, Transcription Elongation, Genetic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Victorian Cancer Agency, Leukemia and Lymphoma Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Controlled gene expression is achieved through the intricate regulation of RNA polymerase II (Pol II) progression through transcription-cycle checkpoints. While the contribution of CDK9 for Pol II pause-release is well established, the requirement for other cyclin-dependent kinases (CDKs) has not been fully elucidated. In this study, we propose a critical role for CDK11 in the Pol II pausing-to-elongation transition at a checkpoint that precedes and is independent from CDK9. Selective CDK11 inhibition or degradation results in acute ablation of RNA synthesis near the beginning of transcriptional units and genome-wide stalling of Pol II at transcription start site (TSS)-proximal regions. High-resolution chromatin immunoprecipitation and precision nuclear run-on assays reveal spatial differences between CDK11- and CDK9-dependent Pol II pause sites, with CDK11 regulating Pol II upstream of the CDK9 checkpoint within the pausing zone. Cancer cells exhibit profound reliance on CDK11, with CDK11 inhibition reducing tumor burden in in vivo models of blood cancer, demonstrating the importance of CDK11-dependent Pol II regulation for aggressive hematological malignancies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclin-Dependent Kinase 9RNA Polymerase IICyclin-Dependent KinasesTranscription Elongation, GeneticHumansAnimalsMiceTranscription Initiation SiteTranscription, GeneticCell Line, Tumor

Stichwörter der Autor:innen

RNA polymerase IIcancer therapycyclin-dependent kinasesgene-expressiontranscription cycle

Substanzen

Cyclin-Dependent Kinase 9RNA Polymerase IICDK9 protein, humanCyclin-Dependent Kinases

Autor:innen und Institutionen

  • The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia; Peter MacCallum Cancer Centre, Laboratory Research Division, Parkville, VIC 3052, Australia.
  • Peter MacCallum Cancer Centre, Laboratory Research Division, Parkville, VIC 3052, Australia.
  • RCSI University of Medicine and Health Sciences, Dublin D02 DH60, Ireland.
  • The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia; Ionopticks, Fitzroy, VIC 3065, Australia.
  • The Walter and Eliza Hall Institute, Parkville, VIC 3052, Australia.
  • The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC 3052, Australia; Peter MacCallum Cancer Centre, Laboratory Research Division, Parkville, VIC 3052, Australia; The Department of Bio…

Förderung

  • National Health and Medical Research Council
  • Victorian Cancer Agency
  • Leukemia and Lymphoma Society
  • Peter MacCallum Foundation
  • Kids' Cancer Project
  • University of Melbourne
  • Australian Cancer Research Foundation
  • Peter MacCallum Cancer Centre

Zitieren

APA

Devlin, J. R., Martin, B., Bartonicek, N., Ting, K., Fan, Z., Todorovski, I., Bjelosevic, F., Verschoor, S., Ciccone, A., Trapani, J. A., Horvath, A., Tinsley, E., Fraser, P., Newbold, A., Sandow, J. J., Muscat, A., Simpson, K. J., Geyer, M., Vervoort, S. J., & Johnstone, R. W. (2025). A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation. Molecular Cell, 85(17), 3256-3274.e14. https://doi.org/10.1016/j.molcel.2025.08.001

Vancouver

Devlin JR, Martin B, Bartonicek N, Ting K, Fan Z, Todorovski I, et al. A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation. Molecular Cell. 2025;85(17):3256-3274.e14. doi:10.1016/j.molcel.2025.08.001

BibTeX
@article{Devlin2025,
  author = {Devlin, Jennifer R and Martin, Ben and Bartonicek, Nenad and Ting, Keziah and Fan, Zheng and Todorovski, Izabela and Bjelosevic, Filip and Verschoor, Sandra and Ciccone, Annette and Trapani, Joseph A and Horvath, Attila and Tinsley, Emily and Fraser, Peter and Newbold, Andrea and Sandow, Jarrod J and Muscat, Andrea and Simpson, Kaylene J and Geyer, Matthias and Vervoort, Stephin J and Johnstone, Ricky W},
  title = {A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation},
  journal = {Molecular Cell},
  year = {2025},
  volume = {85},
  number = {17},
  pages = {3256--3274.e14},
  doi = {10.1016/j.molcel.2025.08.001}
}
Kostenlos starten →